Results 181 to 190 of about 1,878,763 (360)

IGG4-RELATED DISEASE MIMICKING PULMONARY RENAL SYNDROME WITH MPO-ANCA POSITIVITY: IMPORTANCE OF TISSUE DIAGNOSIS [PDF]

, 2019
Tanuja Yalamarti, David Alexandre Chetrit, Melinda Darnell   +2 more
openalex   +1 more source

4D Mapping of ZIF Biocomposites for High Protein Loading and Tunable Release Profiles

Advanced Functional Materials, EarlyView.
Systematic four‐dimensional mapping of zeolitic imidazolate framework biocomposites reveals how precursor ratios, total concentration, and washing define crystalline phase, protein loading, and release kinetics. This comprehensive study identifies conditions yielding record loading (∼85%) and precise phase–property correlations.
Michael R. Hafner, Francesco Carraro, Behnaz Abbasgholi‐NA, Simone Dal Zilio, Max Schmallegger, Helmar Wiltsche, Lingcong Ge, Michael R. Reithofer, Efwita Astria, Laura Villanova, Heinz Amenitsch, Christian Doonan, Paolo Falcaro   +12 more
wiley   +1 more source

Genetic Susceptibility to Nontuberculous Mycobacterial Pulmonary Disease: Is It the Chicken or the Egg? [PDF]

Am J Respir Crit Care Med
Ortega VE, Pienaar E, Escalante P.
europepmc   +1 more source

Correlation between Forced Expiratory Volume in First Second (FEV1) And 6 Minute Walk Distance In Moderate, Severe and Very Severe Chronic Obstructive Pulmonary Disease

, 2013
Anil Kumar Kodavala
openalex   +1 more source

PRELIVE: A Framework for Predicting Lipid Nanoparticles In Vivo Efficacy and Reducing Reliance on Animal Testing

Advanced Functional Materials, EarlyView.
PREdicting LNP In Vivo Efficacy (PRELIVE) framework enables the prediction of lipid nanoparticle (LNPs) organ‐specific delivery through dual modeling approaches. Composition‐based models using formulation parameters and protein corona‐based models using biological fingerprints both achieve high predictive accuracy across multiple organs.
Belal I. Hanafy, Chuan‐En Lu, Kai Liu, Audrey Gallud   +3 more
wiley   +1 more source

Mycobacterium florentinum pulmonary disease: a case report and review of the literature. [PDF]

BMC Infect Dis
Leo F, Polsfuss S, Przewosnik AS, Grohé C, Lange C.   +4 more
europepmc   +1 more source

Nano‐ and Micro‐Sized Solid Materials Used as Antiviral Agents

Advanced Functional Materials, EarlyView.
Due to the rise of viral infections in humans and possible viral outbreaks, the use of nano‐ or micro‐sized materials as antiviral agents is rapidly increasing. This review explores their antiviral properties against RNA and DNA viruses, either as a prevention or a treatment tool, by delving into their mechanisms of action and how to properly assess ...
Orfeas‐Evangelos Plastiras, Imelda Raczkiewicz, Peggy Bouquet, Jean‐Philippe Dacquin, Jeremy Dhainaut, Anne Goffard, Christophe Volkringer   +6 more
wiley   +1 more source

Metabolic reprogramming of macrophages in chronic obstructive pulmonary disease. [PDF]

Front Immunol
Qin Z, Liu W, Huang C, Zhang W.
europepmc   +1 more source

Drug‐Free Thrombolysis Mediated by Physically Activated Micro/Nanoparticles

Advanced Functional Materials, EarlyView.
Overview of particle‐mediated thrombolytic effects (thermal, mechanical, and chemical) and their activating physical stimuli (light, ultrasound, and magnetic field) in drug‐free thrombolysis. ABSTRACT Thrombus‐associated disorders rank among the world's leading causes of death, with ischemic heart disease and stroke as the main contributors.
Pierre Sarfati, Yoann Lalatonne, Cédric Chauvierre   +2 more
wiley   +1 more source

Sclerotherapy embolism: a novel etiology for chronic thromboembolic pulmonary disease. [PDF]

BMC Pulm Med
Çetinkaya Ç, Sağır A, Terzi A, Ermerak NO, Yıldızeli ŞO, Mutlu B, Yıldızeli B.   +6 more
europepmc   +1 more source